copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
HIGHLIGHTS OF PRESCRIBING INFORMATION . . . - ARIKAYCE Instruct patients to read the Instructions for Use before starting ARIKAYCE Instruct patients to only use the Lamira® Nebulizer System to administer ARIKAYCE Advise the patient or caregiver not to use the Lamira Nebulizer System with any other medicine
Find out if ARIKAYCE is right for you Find out if ARIKAYCE® is right for you See Prescribing and Safety Information about ARIKAYCE, including Boxed Warnings
About ARIKAYCE® (amikacin liposome inhalation suspension) ARIKAYCE is used in combination with multidrug therapy for adults who still test positive for MAC lung disease after at least 6 months on multidrug treatment alone ARIKAYCE was approved by FDA using the Limited Population pathway
MAC Support | ARIKAYCE® (amikacin liposome inhalation suspension) Whether you’re considering ARIKAYCE, about to begin treatment, or you’re already on ARIKAYCE, there are resources available throughout your journey Find the right type of support by choosing a tab that best describes your needs
Understanding possible ARIKAYCE side effects Learn about the possible side effects of ARIKAYCE® See most common side effects of ARIKAYCE, inhalation and using a nebulizer for treatment